Semax (5mg)

Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It enhances brain-derived neurotrophic factor (BDNF) expression by up to 300%, modulates serotonergic and dopaminergic systems, and demonstrates potent neuroprotective properties. Clinical research has explored its applications in cognitive enhancement, stroke recovery, and attention deficit conditions. Semax does not exhibit hormonal activity despite its ACTH origin.